InterCure Ltd. (INCR.TA)
ILA 491.2
(1.93%)
ILA 491.2
(1.93%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 329.55 Million ILS | -24.51% |
| 2022 | 436.53 Million ILS | 92.19% |
| 2021 | 227.13 Million ILS | 564.88% |
| 2020 | 34.16 Million ILS | 31.23% |
| 2019 | 26.03 Million ILS | 60.12% |
| 2018 | 16.25 Million ILS | 397.63% |
| 2017 | 3.26 Million ILS | -10.88% |
| 2016 | 3.66 Million ILS | 449.16% |
| 2015 | 667.52 Thousand ILS | -65.65% |
| 2014 | 1.94 Million ILS | -13.5% |
| 2013 | 2.24 Million ILS | -52.13% |
| 2012 | 4.69 Million ILS | -91.41% |
| 2011 | 54.63 Million ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 278.77 Million ILS | 0.0% |
| 2024 Q1 | 278.77 Million ILS | -15.41% |
| 2023 Q2 | 314.19 Million ILS | -10.92% |
| 2023 Q1 | 352.7 Million ILS | -19.2% |
| 2023 FY | 329.55 Million ILS | -24.51% |
| 2023 Q4 | 329.55 Million ILS | 0.0% |
| 2023 Q3 | 329.55 Million ILS | 4.89% |
| 2022 FY | 436.53 Million ILS | 92.19% |
| 2022 Q2 | 290.97 Million ILS | 12.25% |
| 2022 Q1 | 259.22 Million ILS | 14.13% |
| 2022 Q4 | 436.53 Million ILS | 20.8% |
| 2022 Q3 | 361.35 Million ILS | 24.19% |
| 2021 Q3 | 205.48 Million ILS | 42.73% |
| 2021 Q4 | 227.13 Million ILS | 10.53% |
| 2021 FY | 227.13 Million ILS | 564.88% |
| 2021 Q1 | 43.95 Million ILS | 28.66% |
| 2021 Q2 | 143.96 Million ILS | 227.55% |
| 2020 Q3 | 39.35 Million ILS | -7.35% |
| 2020 Q4 | 34.16 Million ILS | -13.19% |
| 2020 FY | 34.16 Million ILS | 31.23% |
| 2020 Q1 | 27.85 Million ILS | 6.98% |
| 2020 Q2 | 42.47 Million ILS | 52.5% |
| 2019 Q1 | - ILS | -100.0% |
| 2019 Q2 | 17.55 Million ILS | 0.0% |
| 2019 Q4 | 26.03 Million ILS | 0.0% |
| 2019 FY | 26.03 Million ILS | 60.12% |
| 2018 Q3 | 16.25 Million ILS | 274.1% |
| 2018 Q4 | 16.25 Million ILS | 0.0% |
| 2018 Q1 | 4.33 Million ILS | 32.72% |
| 2018 Q2 | 4.34 Million ILS | 0.23% |
| 2018 FY | 16.25 Million ILS | 397.63% |
| 2017 Q4 | 3.26 Million ILS | -4.78% |
| 2017 Q2 | 4.68 Million ILS | -3.7% |
| 2017 Q1 | 4.86 Million ILS | 32.59% |
| 2017 FY | 3.26 Million ILS | -10.88% |
| 2017 Q3 | 3.43 Million ILS | -26.7% |
| 2016 Q4 | 3.66 Million ILS | 10.2% |
| 2016 FY | 3.66 Million ILS | 449.16% |
| 2016 Q3 | 3.32 Million ILS | 5.85% |
| 2016 Q2 | 3.14 Million ILS | 2.24% |
| 2016 Q1 | 3.07 Million ILS | 360.45% |
| 2015 Q2 | 1.47 Million ILS | -37.12% |
| 2015 Q3 | 887.98 Thousand ILS | -39.91% |
| 2015 Q1 | 2.35 Million ILS | 20.96% |
| 2015 Q4 | 667.52 Thousand ILS | -24.83% |
| 2015 FY | 667.52 Thousand ILS | -65.65% |
| 2014 FY | 1.94 Million ILS | -13.5% |
| 2014 Q3 | 1.96 Million ILS | -17.27% |
| 2014 Q2 | 2.37 Million ILS | 44.23% |
| 2014 Q1 | 1.64 Million ILS | -26.57% |
| 2014 Q4 | 1.94 Million ILS | -1.27% |
| 2013 Q3 | 2.64 Million ILS | -8.02% |
| 2013 FY | 2.24 Million ILS | -52.13% |
| 2013 Q1 | 4.76 Million ILS | 1.61% |
| 2013 Q2 | 2.87 Million ILS | -39.63% |
| 2013 Q4 | 2.24 Million ILS | -15.16% |
| 2012 FY | 4.69 Million ILS | -91.41% |
| 2012 Q4 | 4.69 Million ILS | 36.19% |
| 2012 Q3 | 3.44 Million ILS | 0.0% |
| 2011 FY | 54.63 Million ILS | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cannabotech LTD | 9.68 Million ILA | -3302.003% |